Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rocío Ramos-Medina

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Medicina Clinica|January 31, 2012
[Intravenous immunoglobulin: immunomodulatory key of the immune system]Rocío Ramos-Medina, Angel L Corbí, Silvia Sánchez-Ramón
Cancers|September 28, 2021
Technical Challenges for CTC Implementation in Breast CancerRocío Ramos-Medina, Sara López-Tarruella, María Del Monte-Millán, et al.
Frontiers in Immunology|March 11, 2017
Activation of Blood CD3<sup>+</sup>CD56<sup>+</sup>CD8<sup>+</sup> T Cells during Pregnancy and Multiple SclerosisClara de Andrés, Lidia Fernández-Paredes, Marta Tejera-Alhambra, et al.
International Journal of Molecular Sciences|July 28, 2012
Perforin expression by CD4+ regulatory T cells increases at multiple sclerosis relapse: sex differencesMarta Tejera-Alhambra, Bárbara Alonso, Roseta Teijeiro, et al.
Clinical Immunology (Orlando, Fla.)|January 14, 2014
Low DPP4 expression and activity in multiple sclerosisMarta Tejera-Alhambra, Armanda Casrouge, Clara de Andrés, et al.
Journal of Neuroimmunology|March 26, 2014
New regulatory CD19(+)CD25(+) B-cell subset in clinically isolated syndrome and multiple sclerosis relapse. Changes after glucocorticoidsClara de Andrés, Marta Tejera-Alhambra, Bárbara Alonso, et al.
Journal of Comparative Effectiveness Research|April 24, 2026
Maximizing the impact of real-world evidence on cancer treatment: what do we need to achieve it?Begoña Bermejo, Rodrigo Dienstmann, Meritxell Bellet, et al.
Plos One|June 4, 2015
Plasma biomarkers discriminate clinical forms of multiple sclerosisMarta Tejera-Alhambra, Armanda Casrouge, Clara de Andrés, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 29, 2024
Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patientsAlejandro Falcón González, María Isabel Gallegos Sancho, Encarnación González Flores, et al.
Breast Cancer Research and Treatment|April 17, 2016
Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trialMilagros González-Rivera, Miriam Lobo, Sara López-Tarruella, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Medicina Clinica|January 31, 2012
[Intravenous immunoglobulin: immunomodulatory key of the immune system]Rocío Ramos-Medina, Angel L Corbí, Silvia Sánchez-Ramón
Cancers|September 28, 2021
Technical Challenges for CTC Implementation in Breast CancerRocío Ramos-Medina, Sara López-Tarruella, María Del Monte-Millán, et al.
Frontiers in Immunology|March 11, 2017
Activation of Blood CD3<sup>+</sup>CD56<sup>+</sup>CD8<sup>+</sup> T Cells during Pregnancy and Multiple SclerosisClara de Andrés, Lidia Fernández-Paredes, Marta Tejera-Alhambra, et al.
International Journal of Molecular Sciences|July 28, 2012
Perforin expression by CD4+ regulatory T cells increases at multiple sclerosis relapse: sex differencesMarta Tejera-Alhambra, Bárbara Alonso, Roseta Teijeiro, et al.
Clinical Immunology (Orlando, Fla.)|January 14, 2014
Low DPP4 expression and activity in multiple sclerosisMarta Tejera-Alhambra, Armanda Casrouge, Clara de Andrés, et al.
Journal of Neuroimmunology|March 26, 2014
New regulatory CD19(+)CD25(+) B-cell subset in clinically isolated syndrome and multiple sclerosis relapse. Changes after glucocorticoidsClara de Andrés, Marta Tejera-Alhambra, Bárbara Alonso, et al.
Journal of Comparative Effectiveness Research|April 24, 2026
Maximizing the impact of real-world evidence on cancer treatment: what do we need to achieve it?Begoña Bermejo, Rodrigo Dienstmann, Meritxell Bellet, et al.
Plos One|June 4, 2015
Plasma biomarkers discriminate clinical forms of multiple sclerosisMarta Tejera-Alhambra, Armanda Casrouge, Clara de Andrés, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 29, 2024
Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patientsAlejandro Falcón González, María Isabel Gallegos Sancho, Encarnación González Flores, et al.
Breast Cancer Research and Treatment|April 17, 2016
Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trialMilagros González-Rivera, Miriam Lobo, Sara López-Tarruella, et al.
Pageof 2